Status:
COMPLETED
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Allergic Conjunctivitis to Tree Pollen or Grass Pollen
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Rationale and objectives: Fluticasone furoate nasal spray (Veramyst) has been shown to improve ocular symptoms when used for the treatment of seasonal allergic rhinitis during the ragweed pollen seas...
Eligibility Criteria
Inclusion
- a documented history of allergic rhinitis and conjunctivitis due to tree pollen and / or grass pollen for two allergy seasons
- positive skin prick test to tree and / or grass
Exclusion
- glaucoma
- cataracts
- acute or chronic sinusitis
- asthma
- chronic obstructive pulmonary disease
- physical nasal obstruction
- pregnant or breastfeeding
- have had a viral or bacterial infections within 2 weeks of the study commencement
- receiving allergen immunotherapy
- have used inhaled corticosteroids within 14 days prior to the study
- have used systemic corticosteroids within 30 days of the study
- travel outside of the geographic area during the 2 week study period
- use of contact lenses during the study period
- use of artificial tears during the study period
- use of eyewash irrigation during the study period
- use of lubricants during the study period
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00891436
Start Date
April 1 2009
End Date
August 1 2009
Last Update
December 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612